FdaApplication
NDA 210632
Identifiers
- fda_app_no: NDA210632
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2019-04-11 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 200MCG/5ML (40MCG/ML) | SOLUTION;INTRAVENOUS |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 500MCG/5ML (100MCG/ML) | SOLUTION;INTRAVENOUS |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 100MCG/5ML (20MCG/ML) | SOLUTION;INTRAVENOUS |
3 products